Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Considering emerging drug resistance in microbes, this work is focused on the synthesis of azole hybrids as novel antimicrobials.  The triazole derivatives were prepared using azide alkyne cycloaddition reaction. The antimicrobial potential of these compounds was evaluated by serial dilution method. A series of azole hybrids containing benzimidazole-1,2,3-triazole skeleton was designed and synthesized via click reaction. Compound  showed notable antimicrobial activity against and (MIC 0.0165 μmol/ml), and gives remarkable radical scavenging activity (IC 0.0092 μmol/ml). The compounds . and are commendable antibacterial and antifungal molecules, even better than established drugs. Molecular docking reveals that compound binds with tyrosyl-tRNA synthetase residues through two H-bonds. Compounds and may be considered valuable lead compounds for further optimization as antimicrobial drugs.

Download full-text PDF

Source
http://dx.doi.org/10.4155/fmc-2020-0321DOI Listing

Publication Analysis

Top Keywords

azole hybrids
12
development novel
4
novel anti-infective
4
anti-infective antioxidant
4
antioxidant azole
4
hybrids wet
4
wet dry
4
dry approach
4
approach considering
4
considering emerging
4

Similar Publications

The epidermal growth factor receptor (EGFR) is a common diver gene for lung cancer (NSCLC), which leads to an increasing death rate worldwide. This study reports the design, synthesis, and biological evaluation of triazole-clubbed pyrimidine derivatives (RDa-RDm) as potential anticancer agents. Thirteen compounds were synthesized and screened against the A549 lung cancer cell line.

View Article and Find Full Text PDF

Magnusiomyces clavatus is an emerging opportunistic fungal pathogen associated with severe systemic infections in immunocompromised patients, mostly among those suffering from hematological malignancies. Despite the increasing clinical significance, genomic data for M. clavatus remain limited.

View Article and Find Full Text PDF

Five novel 1,2,3-triazole/arylidenehydrazide/thiazolidinone hybrid compounds (7-11) were synthesized and characterized using NMR, HRMS, IR, and HPLC purity analysis. The cytotoxicity of these compounds was evaluated on fibroblasts and THP-1 cells, showing that all compounds were nontoxic at the tested concentrations. The wound healing assay revealed that compounds 7, 9, and 10 significantly enhanced wound closure, with a 7.

View Article and Find Full Text PDF

Inhibiting the p53-MDM2 interaction restores the function of the tumour suppressor protein, p53, and offers a promising avenue for anticancer therapies. Herein, a novel series of pyrazoline-derived compounds was developed and synthesised to serve as potential inhibitors of the p53-MDM2 interaction. Scaffold hopping was adopted via replacing the cis-imidazoline core of Nutlin-2 with a pyrazoline core, and molecular docking confirmed the binding orientation of the designed compounds at the p53-MDM2 interaction site.

View Article and Find Full Text PDF

Imidazo[2,1-]thiazole represents a privileged heterocyclic moiety in medicinal chemistry which garnered huge attention among the researchers because of its extensive biological properties and ease of synthetic feasibility. Substituted imidazo[2,1-]thiazole analogs with diverse therapeutic outcomes play a crucial role in the cure or management of various human ailments. The impact of this moiety in drug discovery can be realized from the fact that drugs based on this scaffold are used clinically.

View Article and Find Full Text PDF